Topline data analysis of the phase 1/2 clinical trial evaluating AOC 1001 in adult patients with myotonic dystrophy type 1: MARINA Johnson, N., Day, J., Hamel, J., Thornton, C., Subramony, S., Soltanzadeh, P., Statland, J., Wicklund, M., Arnold, W., Freimer, M., DiTrapani, K., Heusner, C., Chen, C., Cho, H., McEvoy, B., Zhu, Y., Tai, L., Ackermann, E. PERGAMON-ELSEVIER SCIENCE LTD. 2023: S72

View details for DOI 10.1016/j.nmd.2023.07.036

View details for Web of Science ID 001087070800026